Novartis and Medicines for Malaria Venture announce : vimars

There is currently no evidence-based treatment for the smallest babies with malaria The CALINA study tested a new ratio and dose of Coartem® (artemether-...

Related Keywords

United States , Zambia , Burkina Faso , Switzerland , Mali , Nigeria , Kenya , Kigali , W09 , Rwanda , America , Sloan Simpson , Parag Mahanti , Nicole Zinsli Somm , Michael Meo , Jonathan Graham , Isabella Zinck , Marlena Abdinoor , Richard Jarvis , Satoshi Sugimoto , Imke Kappes , Exchange Commission , European Developing Countries Clinical Trials Partnership , Multilateral Initiative On Malaria , Novartis , Linkedin , Instagram , Facebook , Malaria Venture , Multilateral Initiative , Pan African Malaria Conference , Chief Medical Officer , Developing Countries Clinical Trials Partnership , Coartem About , New Artemether Lumefantrine Dispersible Tablet , Neonates Plasmodium , Swiss Stock Exchange Novn , Novartis Pharma Ag , Media Release , Frica , Childrens Health , Malaria , Reimagine Medicine ,